News

• Wes Streeting, Shadow Health Minister, and Peter Kyle, Shadow Science Minister launch Life Sciences Strategy at Stevenage Bioscience Catalyst (SBC).

• Shadow Ministers take part in roundtable discussion with key industry figures including AstraZeneca, GSK, BioIndustry Association (BIA) and Stevenage Bioscience Catalyst and its high growth companies to hear at first hand the opportunities and challenges facing the sector and the vibrant strength of the UK’s life science ecosystem.

Pioneer Group, a company combining laboratory development and operation with venture building, has teamed up with CPI, the independent deep tech innovation organisation, to launch a Golden Ticket programme for innovations in planetary health.

London, UK - Award-winning science communications agency First Create The Media is delighted to announce the appointment of Dr Sarah Hazell as its new Chief Executive Officer.

Founded in 2018 by renowned science writer and broadcaster Dr Kat Arney, First Create The Media has quickly become a prominent player in the life sciences sector. The agency brings together a team of experts with decades of experience to provide strategic communications consultancy and high quality written, audio and video content for innovative companies and the ecosystem that supports them.

Arecor Therapeutics plc

(“Arecor” or the “Company”)

ARECOR ANNOUNCES UPDATE ON INBRX-101

- Sanofi to acquire Inhibrx’s AATD therapy INBRX-101, which incorporates a novel formulation developed under a license agreement using Arecor’s Arestat™ technology, for up to $2.2 billion

- Terms of Arecor’s license agreement are unchanged. Arecor remains entitled to further payments on achievement of certain development, regulatory and commercial milestones along with annual Technology Access Fees post commercialisation